OCGN
OCGN clinical trials: Ocugen, Inc.
Every trial on ClinicalTrials.gov where Ocugen, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 13
- Trials linked
- 12
- As lead sponsor
- 1
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
OCGN on the catalyst calendar · OCGN registry changes
- Primary completion Feb 3, 2026ActualPhase 1/Phase 2NCT06018558Study to Assess the Safety and Efficacy of OCU410 for Geographic AtrophyOcugen · Geographic AtrophyActive, not recruitingOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT06574997Expanded Access Program for RP in AdultsOcugen · Retinitis PigmentosaNo longer availableOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 30, 2028Sponsor estimatePhase 3NCT07770828Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMDOcugen · Dry Age-related Macular DegenerationRecruitingOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 12, 2027Sponsor estimatePhase 3NCT06388200A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaOcugen · Retinitis PigmentosaActive, not recruitingOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 28, 2026Sponsor estimatePhase 2/Phase 3NCT05956626A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseOcugen · Stargardt DiseaseActive, not recruitingOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2026Sponsor estimatePhase 1NCT05802329Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)Ocugen · Center Involved Diabetic Macular EdemaRecruitingOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2027Sponsor estimatePhase 1/Phase 2NCT05203939Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital AmaurosisOcugen · Retinitis PigmentosaActive, not recruitingOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1, 2023Sponsor estimatePhase 2/Phase 3NCT05258669Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy AdultsOcugen · COVID-19Unknown statusOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT05541289Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and OlderOcugen · COVID-19No longer availableOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 25, 2019ActualPhase 3NCT03785340Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)Ocugen · Dry EyeCompletedOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2020ActualPhase 3NCT03591874Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host DiseaseOcugen · Graft Versus Host DiseaseTerminatedOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 29, 2018ActualPhase 2NCT03418727Dry Eye Disease Study With BrimonidineOcugen · Dry EyeCompletedOCGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 13, 2017ActualPhase 1/Phase 2NCT02975557Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)Sandeep Jain, MD · Dry EyeTerminatedOCGNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 13 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner